Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity

作者：Anthony E. Gregory, Erin J. van Schaik, Alycia P. Fratzke, Kasi Russell‐Lodrigue, Christina M. Farris, James E. Samuel · 发表于：Cell Reports Medicine · 年份：2021 · DOI：10.1016/j.xcrm.2021.100461 · 被引用次数：36 · 研究领域：Vector-borne infectious diseases、Yersinia bacterium, plague, ectoparasites research、Insect and Pesticide Research

Q fever is caused by the intracellular bacterium Coxiella burnetii , for which there is no approved vaccine in the United States. A formalin-inactivated whole-cell vaccine (WCV) from virulent C. burnetii NMI provides single-dose long-lived protection, but concerns remain over vaccine reactogenicity. We therefore sought an alternate approach by purifying native C. burnetii antigens from the clonally derived avirulent NMII strain. A soluble bacterial extract, termed Sol II, elicits high-titer, high-avidity antibodies and induces a CD4 T cell response that confers protection in naive mice. In addition, Sol II protects against pulmonary C. burnetii challenge in three animal models without inducing hypersensitivity. An NMI-derived extract, Sol I, enhances protection further and outperforms the WCV gold standard. Collectively, these data represent a promising approach to design highly effective, non-reactogenic Q fever vaccines.